Abstract
A secondary analysis of results from a clinical trial of predictors of response to sertraline treatment for major depressive disorder (MDD) has found that a combination of magnetic resonance imaging (MRI) and clinical data can predict treatment response. These results were specific for sertraline treatment compared with placebo treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
